250
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Powder‐in‐Bottle Formulation of SU011248. Enabling Rapid Progression into Human Clinical Trials

, , , &
Pages 19-25 | Published online: 02 Feb 2004

References

  • Mendel D. B., Laird A. D., Xin X., Louie S. G., Christensen J. G., Li G., Schreck R. E., Abrams T. J., Ngai T. J., Lee L. B., Murray L. J., Carver J., Chan E., Moss K. G., Haznedar J. O., Sukbuntherng J., Blake R. A., Sun L., Tang C., Miller T., Shirazian S., McMahon G., Cherrington J. M. In vivo anti‐tumor activity of SU011248, a novel tyrosine kinase inhibitor targeting VEGF and PDGF receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin. Cancer Res. 2003; 9(1)327–337
  • Allen L. V., Jr., Erickson M. A., III. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids. Am. J. Health‐Syst. Pharm. 1998; 55(18)1915–1920
  • Allen L. V., Jr., Erickson M. A. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids. Am. J. Health‐Syst. Pharm. 1998; 55(17)1804–1809
  • Allen L. V., Jr., Erickson M. A., III. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids. Am. J. Health‐Syst. Pharm. 1996; 53(17)2073–2078
  • Boonme P., Phadoongsombut N., Phoomborplub P., Viriyasom S. Stability of extemporaneous norfloxacin suspension. Drug Devel. Ind. Pharm. 2000; 26(7)777–779
  • Aubry A. F., Sebastian D., Hobson T., Xu J. Q., Rabel S., Xie M., Gray V. In use testing of extemporaneously prepared suspensions of second generation non‐nucleoside reversed transcripts inhibitors in support of Phase I clinical studies. J. Pharm. Biomed. Anal. 2000; 23(200)535–542
  • Ho P.‐C., Ghose K., Saville D., Wanwimolruk S. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Eur. J. Clin. Pharmacol. 2000; 56(9–10)693–698
  • Takanaga H., Ohnishi A., Matsuo H., Murakami H., Sata H., Kuroda K., Urae A., Higuchi S., Sawada Y. Pharmacokinetic analysis of felodipine–grapefruit juice interaction based on an irreversible enzyme inhibition model. Br. J. Clin. Pharmacol. 2000; 49(1)49–58

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.